Intelligent Medicine Acquisition Stock Fundamentals
Intelligent Medicine Acquisition fundamentals help investors to digest information that contributes to Intelligent Medicine's financial success or failures. It also enables traders to predict the movement of Intelligent Stock. The fundamental analysis module provides a way to measure Intelligent Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intelligent Medicine stock.
Intelligent |
Intelligent Medicine Acquisition Company Cash And Equivalents Analysis
Intelligent Medicine's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Intelligent Medicine Cash And Equivalents | 69.33 K |
Most of Intelligent Medicine's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intelligent Medicine Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Intelligent Medicine Acquisition has 69.33 K in Cash And Equivalents. This is 100.0% lower than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The cash and equivalents for all United States stocks is 100.0% higher than that of the company.
Intelligent Medicine Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Intelligent Medicine's current stock value. Our valuation model uses many indicators to compare Intelligent Medicine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intelligent Medicine competition to find correlations between indicators driving Intelligent Medicine's intrinsic value. More Info.Intelligent Medicine Acquisition is currently regarded as number one stock in ebitda category among its peers. It also is currently regarded as number one stock in net income category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Intelligent Medicine by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Intelligent Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intelligent Medicine's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intelligent Medicine could also be used in its relative valuation, which is a method of valuing Intelligent Medicine by comparing valuation metrics of similar companies.Intelligent Medicine is currently under evaluation in cash and equivalents category among its peers.
Intelligent Fundamentals
EBITDA | (14.54 M) | |||
Net Income | 11.41 M | |||
Cash And Equivalents | 69.33 K | |||
Cash Per Share | 0.01 X | |||
Total Debt | 165 K | |||
Book Value Per Share | 0 X | |||
Cash Flow From Operations | (866.9 K) | |||
Total Asset | 214.03 M | |||
Retained Earnings | (10.86 M) | |||
Working Capital | (891.12 K) | |||
Z Score | -0.3 | |||
Net Asset | 214.03 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Intelligent Stock
If you are still planning to invest in Intelligent Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intelligent Medicine's history and understand the potential risks before investing.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |